News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
345 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38488)
2025 (26421)
Month
January (4451)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
1 (5)
2 (321)
3 (345)
4 (310)
5 (394)
6 (122)
7 (3)
8 (3)
9 (242)
10 (360)
11 (259)
12 (398)
13 (145)
14 (4)
15 (16)
16 (326)
17 (318)
18 (251)
19 (262)
20 (127)
21 (4)
22 (5)
23 (228)
24 (302)
25 (222)
26 (289)
27 (144)
28 (1)
29 (3)
30 (42)
31 (252)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
BioCapital
NextCure to Present at the BofA Securities 2022 Healthcare Conference
NextCure, Inc. today announced that it will participate in a fireside chat at the BofA Securities 2022 Healthcare Conference in Las Vegas on Tuesday May 10th at 10:40 am PT.
May 3, 2022
·
2 min read
Genetown
Ring Therapeutics Announces Two Presentations at the Upcoming 25th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
Ring Therapeutics today announced two upcoming presentations at the 25th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT), to be held from May 16-19, 2022 in Washington, DC.
May 3, 2022
·
2 min read
Genetown
Sesen Bio Provides Strategic Update
Sesen Bio today announced that it has initiated a process to review strategic alternatives with the goal of maximizing shareholder value.
May 3, 2022
·
8 min read
Business
Seismic Therapeutic Appoints Maude Tessier, PhD, as Chief Business Officer
Seismic Therapeutic, Inc. today announced the appointment of Maude Tessier, PhD, as Chief Business Officer.
May 3, 2022
·
3 min read
Business
Cerus Corporation Announces New Manufacturing and Supply Agreement With Fresenius Kabi For INTERCEPT Blood System Sets
Cerus Corporation (Nasdaq: CERS) today announced that it has signed a ten-year agreement with Fresenius Kabi for the production of INTERCEPT Blood System sets.
May 3, 2022
·
3 min read
Genetown
Pressure BioSciences to Present at the Planet MicroCap Showcase 2022 on May 4, 2022
Pressure BioSciences, Inc. today announced the Company’s participation as a presenter at the May 3-5 Planet MicroCap Showcase 2022.
May 3, 2022
·
5 min read
Pharm Country
U.S. FDA Accepts Supplemental New Drug Application (sNDA) and Grants Priority Review for NUBEQA® (darolutamide) in Combination with Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Bayer today announced the U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) and granted Priority Review for the oral androgen receptor inhibitor (ARi) NUBEQA ® .
May 3, 2022
·
10 min read
Business
UroGen Pharma to Report First Quarter 2022 Financial Results on Tuesday, May 10, 2022
UroGen Pharma Ltd. today announced that it will report first quarter 2022 financial results on Tuesday, May 10, 2022, prior to the open of the market.
May 3, 2022
·
1 min read
Business
Yield10 Bioscience to Announce First Quarter 2022 Financial Results and Host a Conference Call on Wednesday, May 11, 2022
Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its first quarter 2022 financial results and provide a corporate update on Wednesday, May 11, 2022.
May 3, 2022
·
1 min read
Business
CorMedix Inc. to Report First Quarter 2022 Financial Results and Provide a Corporate Update on May 12
CorMedix Inc. today announced that it will report its financial results for the first quarter ended March 31, 2022, after the market close on Thursday, May 12, 2022, and will host a corporate update conference call at 4:30pm Eastern Time.
May 3, 2022
·
2 min read
Previous
21 of 35
Next